FindMyKOL
Clinical trialNCT07444814RecruitingPhase 1Interventional

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

SponsorWhitehawk Therapeutics, Inc.Enrollment226Endometrial CancerNon-squamous EGFR Wt NSCLCOvarian CancerOvarian Cancer MetastaticOvarian Cancer Metastatic RecurrentPROC+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

HWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody drug conjugate (ADC), in adult participants with advanced or metastatic solid tumors known to be expressing PTK7. The study employs a sequential dose escalation and dose expansion design without a control group.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arkansas

    Little Rock, Arkansas, United States

    Michael Birrer, MD
    Recruiting
  • Ucla - Hematology/oncology Clinical Research Unit

    Los Angeles, California, United States

    Aaron Lisberg, MD
    Not, yet, recruiting
  • St. Francis Medical Center (osf Healthcare)

    Peoria, Illinois, United States

    Michelle Rowland, MD
    Recruiting
  • Start - Midwest

    Grand Rapids, Michigan, United States

    Manish Sharma
    Recruiting
  • Hackensack University Medical Center - John Theurer Cancer Center

    Hackensack, New Jersey, United States

    Miguel Gonzalez, MD
    Recruiting
  • Roswell Park Comprehensive Care Center

    Buffalo, New York, United States

    Bailey Fitzgerald, MD
    Recruiting
  • University Hospital - Cleveland Medical Center

    Cleveland, Ohio, United States

    Matthew MIrsky, MD
    Recruiting
  • Next Oncology - Austin

    Austin, Texas, United States

    Recruiting
  • Next - Oncology - Houston

    Houston, Texas, United States

    Jennifer Segar, MD
    Recruiting
  • Start - San Antonio

    San Antonio, Texas, United States

    Recruiting
  • Next Oncology - Virginia Cancer Specialists

    Fairfax, Virginia, United States

    Alexander Spira, MD, PhD
    Recruiting
  • Fred Hutchinson Cancer Center

    Seattle, Washington, United States

    Lei Deng, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

HWK-007
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Dec 2025
Primary completion
31 Oct 2028
Completion
31 Dec 2028
Last update posted
5 Aug 2026
Registered enrollment
226
Registry id
NCT07444814

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.